These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 13587424)

  • 21. Quantitative concepts related to prothrombin and autoprothrombin I activity.
    JOHNSON SA; PENNER JA; SEEGERS WH
    Can J Biochem Physiol; 1956 Sep; 34(5):887-92. PubMed ID: 13364717
    [No Abstract]   [Full Text] [Related]  

  • 22. Turnover of prothrombin, factor VII and factor IX in a patient with hemophilia A.
    HJORT PF; EGEBERG O; MIKKELSEN S
    Scand J Clin Lab Invest; 1961; 13():668-72. PubMed ID: 13907816
    [No Abstract]   [Full Text] [Related]  

  • 23. Formation of autoprothrombin in solutions containing purified prothrombin and purified platelet factor 3.
    SEEGERS WH; ALKJAERSIG N; JOHNSON SA
    Am J Physiol; 1955 Jun; 181(3):589-94. PubMed ID: 13238607
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of phosphatidylserine in hemocoagulating action of factors V, VII and autoprothrombin C].
    Byshevskiĭ ASh; Mukhacheva IA; Lapuseva TM
    Biokhimiia; 1978 Jan; 43(1):78-82. PubMed ID: 623847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Some physicochemical properties of bovine autoprothrombin II.
    HARMISON CR; SEEGERS WH
    J Biol Chem; 1962 Oct; 237():3074-6. PubMed ID: 13952856
    [No Abstract]   [Full Text] [Related]  

  • 26. The mode of action of phenylindanedione.
    WALKER W; HUNTER RB
    J Clin Pathol; 1954 Aug; 7(3):249-51. PubMed ID: 13192203
    [No Abstract]   [Full Text] [Related]  

  • 27. [Methodological and clinical studies on the isolated determination of coagulation factor VII and prothrombin].
    WITTE S; DIRNBERGER P
    Dtsch Arch Klin Med; 1952; 199(5-6):492-501. PubMed ID: 13033518
    [No Abstract]   [Full Text] [Related]  

  • 28. [Influence of massive doses if vitamin K1 on the coagulation factors prothrombin, factor V and factor VII in liver diseases].
    GUNTHER PG; KIEFER E
    Med Klin; 1955 Nov; 50(46):1944-8. PubMed ID: 13287765
    [No Abstract]   [Full Text] [Related]  

  • 29. STUDIES ON PROCONVERTIN (FACTOR VII) II. PURIFICATION.
    PRYDZ H
    Scand J Clin Lab Invest; 1964; 16():101-7. PubMed ID: 14124442
    [No Abstract]   [Full Text] [Related]  

  • 30. Some biochemical and electrophoretic studies on purified prothrombin, factor VII (proconvertin) and factor X (Stuart).
    TISHKOFF GH; PECHET L; ALEXANDER B
    Blood; 1960 May; 15():778-90. PubMed ID: 13838500
    [No Abstract]   [Full Text] [Related]  

  • 31. The blood coagulation mechanism with especial reference to the prothrombin-proconvertin contents of plasma during long-term ACTH or cortisone therapy.
    FISCHER F; LUND E
    Acta Med Scand; 1954; 149(3):179-85. PubMed ID: 13180225
    [No Abstract]   [Full Text] [Related]  

  • 32. A study of the relationship of concentrations of prothrombin, proconvertin, and proaccelerin to three methods for measuring prothrombin time.
    GONYEA LM; HJORT P; OWREN PA
    J Lab Clin Med; 1956 Oct; 48(4):624-33. PubMed ID: 13367602
    [No Abstract]   [Full Text] [Related]  

  • 33. [The mechanism of formation of coagulating factors prothrombin and factor VII].
    LASCH HG; ROKA L
    Klin Wochenschr; 1954 May; 32(19-20):460-4. PubMed ID: 13164277
    [No Abstract]   [Full Text] [Related]  

  • 34. [Behavior of prothrombin and of factor VII in various pediatric diseases].
    DIGIGLIO G; FELICI W; STEGAGNO GA
    Arch Ital Pediatr Pueric; 1956; 18(1):37-64. PubMed ID: 13373544
    [No Abstract]   [Full Text] [Related]  

  • 35. [Studies on the prothrombin complex, II. Behavior of prothrombin, factor VII, IX and X during column chromatography on anion exchangesRS].
    Voss D
    Hoppe Seylers Z Physiol Chem; 1967 Sep; 348(9):1172-8. PubMed ID: 5588277
    [No Abstract]   [Full Text] [Related]  

  • 36. [Plasma prothrombin-proconvertin content following therapeutic doses of heparin].
    MUNCK O
    Ugeskr Laeger; 1956 Jan; 118(2):38-9. PubMed ID: 13312131
    [No Abstract]   [Full Text] [Related]  

  • 37. [Changes in the clotting factors prothrombin & factor VII in hyper- & hypo-circulatory circulation shifts in cats].
    LASCH HG; MECHELKE K; NUSSER E
    Dtsch Arch Klin Med; 1957; 204(1):1-21. PubMed ID: 13447622
    [No Abstract]   [Full Text] [Related]  

  • 38. Blood coagulation in pregnancy: proconvertin and prothrombin, and the hypercoagulable state.
    ALEXANDER B; MEYERS L; KENNY J; GOLDSTEIN R; GUREWICH V; GRINSPOON L
    N Engl J Med; 1956 Feb; 254(8):358-63. PubMed ID: 13288790
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on the anticoagulant phenindione. IV. Its multiphasic effect on the coagulation mechanism.
    ADAMIS D; KIMBALL D; SISE HS
    J Lab Clin Med; 1957 Jan; 49(1):69-83. PubMed ID: 13385578
    [No Abstract]   [Full Text] [Related]  

  • 40. Blood coagulation. Role of Hageman protein (F-XII) and autoprothrombin II (F-IX?) in the activation of autoprothrombin 3 (F-X).
    Seegers WH; Grammens GL; McCoy LE
    Thromb Diath Haemorrh; 1970 Dec; 24(3):345-51. PubMed ID: 5533980
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.